Atlas Trials

Advesya SAS

1 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Advesya SAS

RecordFirmDate
An Adaptive Open-label Multicentre Phase 1/2 Trial, to Determine the Recommended Phase 2 Dose of CCTx-001, and to Assess Safety, Tolerability, and Clinical Activity in Patients With Relapsed/Refractory Acute Myeloid Leukaemia (NCT06281847)Advesya SAS2025-12-01

Track Advesya SAS automatically

Every clearance here is in the API, with alerts when new ones post.